Affinity Asset Advisors »

Roivant Sciences Ltd Shs Isin #bmg762791017 shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Roivant Sciences Ltd Shs Isin #bmg762791017

Tip: Access up to 7 years of quarterly data

All positions including Roivant Sciences Ltd Shs Isin #bmg762791017 held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Roivant Sciences Ltd Shs Isin #bmg762791017 by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.8M 150k 11.68
2023-03-31 $738k 100k 7.38

More positions owned by Affinity Asset Advisors

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Apogee Therapeutics (APGE)
Establishment Labs Holdings Ord (ESTA)
Cymabay Therapeutics
Immunovant (IMVT)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Madrigal Pharmaceuticals (MDGL)
Xenon Pharmaceuticals (XENE)
Alkermes SHS Call Option (ALKS)
Kura Oncology (KURA)
Astria Therapeutics (ATXS)
Morphic Hldg (MORF)

View all positions for Affinity Asset Advisors

Top funds holding Roivant Sciences Ltd Shs Isin #bmg762791017

QVT Financial
Viking Global Investors
Wellington Management Company
Baker Bros. Advisors
Vanguard Group
Anchorage Capital Group
venBio Select Advisor
T. Rowe Price Associates
Citadel Advisors
Norges Bank Investment Management
BVF
Bank of New York Mellon
Octagon Capital Advisors
Tejara Capital
Charles Schwab Investment Management

View all funds holding Roivant Sciences Ltd Shs Isin #bmg762791017